5 - 6 May 2021, virtual event
The Financial Times US Pharma and Biotech Summit brings together industry leaders and experts to share insights and perspectives on how the pharma industry is adapting to meet a new set of challenges and opportunities for the post-pandemic era..
Chief Executive Officer, ICON plc
2:45pm - 3:05pm EST
Fireside chat: 'Post Pandemic Opportunities in Clinical Development'
The challenges of the pandemic have pushed CROs and sponsors to embrace new ways of conducting clinical trials that offer significant advantages going forward. ICON CEO Dr. Steve Cutler discusses these developments in a post-pandemic clinical trials landscape and looks at some of the recent developments in the CRO market.
Alisha Alaimo, President, Biogen U.S.
Karan Arora, Chief Commercial Digital Officer, Global Vice President, AstraZeneca
Stéphane Bancel, CEO, Moderna Therapeutics
Jenn Bonilla, SVP, Portfolio Strategy, Management and Operations, Gilead Sciences
Giovanni Caforio, Chairman and CEO, Bristol Myers Squibb
Courtney Piron, Head, North America Public Affairs, Novartis
Lidia Fonseca, EVP, Chief Digital and Technology Officer, Pfizer
Anne Heatherington, SVP, Head of Data Sciences Institute, Takeda
Aran Maree, CMO, Pharmaceuticals, Johnson & Johnson
MCynthia Pussinen, CTO, Spark Therapeutics
John Reites, CEO, THREAD
Christi Shaw, CEO, Kite
George Yancopoulos, President and CSO, Regeneron